top of page
 Paxlovid Rx for COVID - 04 May 2022

Paxlovid (retonavir), an oral anti-viral medication, is available for mild to moderate COVID.  There are criteria for who qualifies for treatment, and the updated information is maintained by AHS on their Paxlovid website.

​

People who qualify are:

  • Unvaccinated or have only received one dose of a COVID-19 vaccine and are:

    • 55 years of age or older, regardless of other health conditions

    • Indigenous, and 45 years of age or older, regardless of other health conditions

    • Pregnant (if potential benefits outweigh the potential risks to the fetus.)

    • 18 years of age or older with a co-morbidity

    • diabetes (taking medication for treatment)

      • obesity (BMI >30)

      • chronic kidney disease (estimated glomerular filtration rate, <60 ml per minute per 1.73 m2 of body-surface area)

      • congestive heart failure (New York Heart Association class II, III, or IV)

      • chronic obstructive pulmonary disease, and moderate-to-severe asthma

  • Residents of long-term care, designated supportive living (DSL4, 4D), regardless of vaccination status.

  • Regardless of their COVID-19 vaccine status, immunocompromised patients, including but not limited to:

    • Transplant patients (solid organ or stem cell)

    • Oncology patients that have received a dose of any IV or oral chemotherapy or other immunosuppressive treatment since December 2020

    • Patients with inflammatory conditions (e.g. rheumatoid arthritis, lupus, inflammatory bowel disease) who have received a dose of any systemic immunosuppressive treatment since December 2020. 

​

You must also:

  • Have mild to moderate flu-like symptoms typical of COVID for no more than 5 days

  • Be reliably positive on a COVID test (PCR swab test, Rapid Antigen Test)

  • Have normal kidney function, no pulmonary hypertension, no TB, no allergy to retonavir

​

If you are sick and meet the above criteria, or if you are uncertain, please call us for a call-back.  The use of Paxlovid has a short time window for effectiveness.

 

If you have severe symptoms of chest discomfort, shortness of breath, declining responsiveness, call 811 or 911.

​

ama_logo_print_main_edited.png
bottom of page